ACTRIMS 2020: Post-Conference Perspectives
Investigators caution health care providers to consider specific risks of severe COVID-19 infection before initiating this therapy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Dravet Syndrome Medication Stiripentol Effective in Real World Settings Across Various Patient Profiles
2
Merck’s Novel Antibody MK-2214 Receives FDA Fast-Track Designation Following Phase 1 Results
3
US Survey Reveals Underuse of Dravet Syndrome–Specific Antiseizure Medications in the Clinic
4
AES Presentations Highlight Zorevunersen as Disease-Modifying Treatment for Dravet Syndrome
5
